IPO · GAUDIUMIVF

Gaudium IVF and Women Health IPO listing gain & performance.

Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.

· data for the trading session of Wed 18 Nov 2026

Issue price₹79.00₹75 to ₹79
Listing gain+5.1%at the opening price
Since the IPO+23.3%₹97.40 on 18 Nov
Subscribed7.27×times in total

Gaudium IVF and Women Health IPO in brief

Written from NSE’s data, as of 18 Nov 2026.

Gaudium IVF and Women Health came to the market at ₹79.00 a share (price band ₹75 to ₹79), with bidding open from 20 February to 24 February 2026. It listed on NSE on Friday, 27 February 2026, opening at ₹83.00, a gain of 5.1% on the issue price, and closed the first day +1.6% from the issue price after trading between +0.6% and +10.3%. NSE did not publish a delivery figure for the listing day.

The issue was subscribed 7.27× in total, institutions (QIB) 1.62×, HNIs (NII) 14.1×, retail investors 7.60×. Across the 31 IPOs subscribed 3–10×, the median listing gain was +4.4%.

Its listing gain beat 41% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 6 months after listing it was +48.4% from the issue price and +46.1% from the first-day close, while NIFTY 50 moved -5.2% over the same days. Its highest price so far was 107% above the issue price (22 Jul 2026) and its lowest 12% below it (23 Mar 2026); it closed below the issue price on 7% of the days since listing.

Share price since listing

Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.

IPO ₹7927 Feb 202618 Nov 2026₹97

Subscription

Times subscribed by investor group, NSE + BSE bids as reported by NSE.

Qualified institutions (QIB)1.62×
Non-institutional (NII / HNI)14.1×
NII, bids above ₹10 lakh12.7×
NII, ₹2–10 lakh16.7×
Retail investors7.60×
Total7.27×

For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.

Listing day

Friday 27 February 2026.

Open+5.1%vs issue price
High / low+10% / +1%vs issue price
Close+1.6%vs issue price
DeliveryNot published₹74 Cr traded

Returns after listing

Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.

After listingFrom issue priceFrom first-day closeNIFTY 50Median IPO (from issue)
1 week9 Mar 2026-6.8%-8.3%-4.6%+8.0%
1 month2 Apr 2026-3.2%-4.7%-9.8%+9.4%
3 months5 Jun 2026+33.9%+31.8%-7.2%+10.3%
6 months3 Sep 2026+48.4%+46.1%-5.2%+8.0%

IPO details

From NSE’s issue page.

Company
Gaudium IVF and Women Health
NSE symbol
GAUDIUMIVF
Board
Main board
Industry
Healthcare Service Provider
Bidding
20 Feb – 24 Feb 2026
Price band
₹75 to ₹79
Issue price
₹79.00
Issue size
Initial Public Offer of Fresh Issue 1,13,92,500 Equity Shares and Offer for Sale 94,93,700 Equity Shares (Including Anchor investors portion of 62,65,860 Equity Shares)
Bid lot
189 Equity Shares and in multiples thereof
Listing date
27 February 2026
ISIN
INE0P8B01020

Gaudium IVF and Women He share price, delivery & results →How all IPOs did after listing →IPO calendar →

Questions

What was the listing gain of the Gaudium IVF and Women Health IPO?
Gaudium IVF and Women Health listed on 27 February 2026 and opened +5.1% against its issue price of ₹79.00; it closed the first day +1.6% from the issue price.
What is the Gaudium IVF and Women Health share price now against the IPO price?
At the close of 18 November 2026, Gaudium IVF and Women Health was at ₹97.40, +23.3% from the IPO price of ₹79.00.
How many times was the Gaudium IVF and Women Health IPO subscribed?
Gaudium IVF and Women Health’s IPO was subscribed 7.27× in total; QIB 1.62×; NII 14.1×; retail 7.60× (NSE + BSE bids, as reported by NSE).
When was the Gaudium IVF and Women Health IPO open?
Bidding ran from 20 February to 24 February 2026 at a price band of ₹75 to ₹79; the shares listed on 27 February 2026.

From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.